Cargando…

Dose–Response Relationship Between BMI and Hyperuricemia

OBJECTIVE: The purpose of the current study is to explore the demographic characteristics of hyperuricemia in China. STUDY DESIGN: The cross-sectional study was conducted, and the CHARLS dataset in 2011 was used. METHODS: Logistic regression model was used to assess the association between BMI and h...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lu, He, Zhen’an, Gu, Xuan, Cheng, Hao, Li, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594780/
https://www.ncbi.nlm.nih.gov/pubmed/34795514
http://dx.doi.org/10.2147/IJGM.S341622
_version_ 1784600053520793600
author Yang, Lu
He, Zhen’an
Gu, Xuan
Cheng, Hao
Li, Lin
author_facet Yang, Lu
He, Zhen’an
Gu, Xuan
Cheng, Hao
Li, Lin
author_sort Yang, Lu
collection PubMed
description OBJECTIVE: The purpose of the current study is to explore the demographic characteristics of hyperuricemia in China. STUDY DESIGN: The cross-sectional study was conducted, and the CHARLS dataset in 2011 was used. METHODS: Logistic regression model was used to assess the association between BMI and hyperuricemia. We also used restricted cubic spline with three knots to assess the dose–response relationship. To investigate the differences in dose–response relationships in various groups, stratification analysis was conducted. RESULTS: Of the 9408 middle and older participants, those who were overweight or obese had higher risk for hyperuricemia (OR=1.26, 95% CI=1.01–1.57; OR=1.90, 95% CI=1.46–2.47). In the subgroup, the effect of obesity on hyperuricemia was robust in varying gender and age. However, among overweight group, those with being male and aged over 60 years had higher risk for hyperuricemia (male: OR=1.42, 95% CI=1.07–1.90; over 60 years: OR=1.28, 95% CI=1.03–1.60). A dose-response relationship was examined between BMI and the risk of hyperuricemia. The result showed that the odds ratio of hyperuricemia and BMI displayed U-shaped nonlinear relationship (P(trend)<0.001, non-linear P<0.001). CONCLUSION: The association between BMI and hyperuricemia showed positive relationship. Specifically, the group with male and age over 60 years had higher risk of hyperuricemia along with increased weight.
format Online
Article
Text
id pubmed-8594780
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85947802021-11-17 Dose–Response Relationship Between BMI and Hyperuricemia Yang, Lu He, Zhen’an Gu, Xuan Cheng, Hao Li, Lin Int J Gen Med Original Research OBJECTIVE: The purpose of the current study is to explore the demographic characteristics of hyperuricemia in China. STUDY DESIGN: The cross-sectional study was conducted, and the CHARLS dataset in 2011 was used. METHODS: Logistic regression model was used to assess the association between BMI and hyperuricemia. We also used restricted cubic spline with three knots to assess the dose–response relationship. To investigate the differences in dose–response relationships in various groups, stratification analysis was conducted. RESULTS: Of the 9408 middle and older participants, those who were overweight or obese had higher risk for hyperuricemia (OR=1.26, 95% CI=1.01–1.57; OR=1.90, 95% CI=1.46–2.47). In the subgroup, the effect of obesity on hyperuricemia was robust in varying gender and age. However, among overweight group, those with being male and aged over 60 years had higher risk for hyperuricemia (male: OR=1.42, 95% CI=1.07–1.90; over 60 years: OR=1.28, 95% CI=1.03–1.60). A dose-response relationship was examined between BMI and the risk of hyperuricemia. The result showed that the odds ratio of hyperuricemia and BMI displayed U-shaped nonlinear relationship (P(trend)<0.001, non-linear P<0.001). CONCLUSION: The association between BMI and hyperuricemia showed positive relationship. Specifically, the group with male and age over 60 years had higher risk of hyperuricemia along with increased weight. Dove 2021-11-12 /pmc/articles/PMC8594780/ /pubmed/34795514 http://dx.doi.org/10.2147/IJGM.S341622 Text en © 2021 Yang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Yang, Lu
He, Zhen’an
Gu, Xuan
Cheng, Hao
Li, Lin
Dose–Response Relationship Between BMI and Hyperuricemia
title Dose–Response Relationship Between BMI and Hyperuricemia
title_full Dose–Response Relationship Between BMI and Hyperuricemia
title_fullStr Dose–Response Relationship Between BMI and Hyperuricemia
title_full_unstemmed Dose–Response Relationship Between BMI and Hyperuricemia
title_short Dose–Response Relationship Between BMI and Hyperuricemia
title_sort dose–response relationship between bmi and hyperuricemia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594780/
https://www.ncbi.nlm.nih.gov/pubmed/34795514
http://dx.doi.org/10.2147/IJGM.S341622
work_keys_str_mv AT yanglu doseresponserelationshipbetweenbmiandhyperuricemia
AT hezhenan doseresponserelationshipbetweenbmiandhyperuricemia
AT guxuan doseresponserelationshipbetweenbmiandhyperuricemia
AT chenghao doseresponserelationshipbetweenbmiandhyperuricemia
AT lilin doseresponserelationshipbetweenbmiandhyperuricemia